Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...

Fermentation has evolved into precision fermentation, utilizing biotechnology to engineer microorganisms that produce ...

The Central Drugs Standard Control Organization (CDSCO) has announced that all applications related to Post Approval Changes ...

The Organoid COMMONS (Consortium for Organoid Manufacturing, Measurement, Optimization, and Network for Standards) is pleased to announce formal establishment of its first Governing Board, appointment ...

Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Ngenla Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The Ngenla ...

Vietnam is revising its priority high-tech portfolio to better align with global innovation trends and evolving development ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

The Monoclonal Antibodies Market has emerged as one of the most transformative sectors within the global biopharmaceutical ...

Upfront cash fee with total value of $7.0 million, comprised of a $3.5 million cash payment and $3.5 million in-kind payment in the form of a ...

The new arrangement builds upon the existing mpox vaccine licence and manufacturing partnership between the two companies.

DENVER, March 11, 2026 (GLOBE NEWSWIRE)-- 247marketnews.com-- In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed ...

Public health has its own bracket of champions: breakthroughs that eliminated deadly diseases, revolutionized surgery, and opened entirely new doors in medicine. From vaccines to mRNA technology, ...